These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7200175)

  • 1. Studies on middle ear effusions.
    Juhn SK
    Laryngoscope; 1982 Mar; 92(3):287-91. PubMed ID: 7200175
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytological and immunochemical characterization of middle ear effusions: an experimental approach.
    Stenfors LE; Hellström S; Angström T; Johansson U
    Auris Nasus Larynx; 1985; 12 Suppl 1():S83-5. PubMed ID: 3835945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of middle ear effusion analyses.
    Juhn SK; Meyerhoff WL; Paparella MM
    Laryngoscope; 1981 Jun; 91(6):1012-5. PubMed ID: 7242181
    [No Abstract]   [Full Text] [Related]  

  • 4. Arachidonic acid metabolites in otitis media pathogenesis.
    Jung TT
    Ann Otol Rhinol Laryngol Suppl; 1988; 132():14-8. PubMed ID: 3132884
    [No Abstract]   [Full Text] [Related]  

  • 5. The kinetics of penicillin diffusion in serum and middle ear effusions in experimentally induced otitis media.
    Juhn SK; Edlin J; Jung TT; Giebink GS
    Arch Otorhinolaryngol; 1986; 243(3):183-5. PubMed ID: 3753296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitors in middle ear effusions.
    Carlsson B; Lundberg C; Ohlsson K
    Ann Otol Rhinol Laryngol; 1981; 90(1 Pt 1):38-41. PubMed ID: 6162410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic and biochemical study of vascular permeability of the middle ear mucosa in experimental otitis media.
    Sakagami M; Harada T; Juhn SK; Duvall AJ
    Ann Otol Rhinol Laryngol; 1990 Aug; 99(8):654-9. PubMed ID: 1696441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of otitis media.
    Paparella MM; Kim CS; Goycoolea MV; Giebink S
    Ann Otol Rhinol Laryngol; 1977; 86(4 Pt 1):481-92. PubMed ID: 18976
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fluorometric assay of histamine levels in middle ear effusions of secretory otitis media].
    Endo S; Awataguchi T; Suzuki S; Shibuya M; Takasaka T; Kawamoto K
    Nihon Jibiinkoka Gakkai Kaiho; 1985 Nov; 88(11):1541-7. PubMed ID: 3834050
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoelectrophoretic study of proteins in middle ear effusion. A study of secretory otitis media in children.
    Pahor AL; Sözen N; Beetham R; Raine DN
    J Laryngol Otol; 1976 Nov; 90(11):1033-40. PubMed ID: 1003029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan in experimental serous and purulent otitis media.
    Laurent C; Hellström S; Tengblad A; Lilja K
    Ann Otol Rhinol Laryngol; 1989 Sep; 98(9):736-40. PubMed ID: 2782807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and management of the discharging ear.
    Burke P
    Practitioner; 1989 May; 233(1469):742, 744, 746. PubMed ID: 2602312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children.
    Pukander J; Rautianen M
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():53-61. PubMed ID: 8818846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil.
    Haddad J; Isaacson G; Respler DS; Hart RW; Yilmaz HM; Collins JJ; Bluestone CD
    Pediatr Infect Dis J; 1991 Apr; 10(4):294-8. PubMed ID: 2062625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial and polymorphonuclear leukocyte contribution to middle ear inflammation in chronic otitis media with effusion.
    Giebink GS; Carlson BA; Hetherington SV; Hostetter MK; Le CT; Juhn SK
    Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):398-402. PubMed ID: 4040727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic glycosaminoglycans (mucopolysaccharides) in middle ear effusions.
    Sato N; Mogi G
    Auris Nasus Larynx; 1985; 12 Suppl 1():S151-3. PubMed ID: 2941003
    [No Abstract]   [Full Text] [Related]  

  • 17. Lactoferrin in middle ear effusion.
    Suzuki T; Somekawa Y; Yamanaka N; Niida Y; Kataura A
    Auris Nasus Larynx; 1985; 12 Suppl 1():S154-5. PubMed ID: 3915202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media.
    Edén T; Anari M; Ernstson S; Sundberg L
    Scand J Infect Dis Suppl; 1983; 39():48-52. PubMed ID: 6580733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration characteristics of trimethoprim-sulfamethoxazole in middle ear fluid of patients with chronic serous otitis media.
    Klimek JJ; Bates TR; Nightingale C; Lehmann WB; Ziemniak JA; Quintiliani R
    J Pediatr; 1980 Jun; 96(6):1087-9. PubMed ID: 7189554
    [No Abstract]   [Full Text] [Related]  

  • 20. Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B.
    Duah V; Huang Z; Val S; DeMason C; Poley M; Preciado D
    Int J Pediatr Otorhinolaryngol; 2016 Nov; 90():133-137. PubMed ID: 27729120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.